Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study

被引:15
作者
Cashin, Peter H. [1 ]
Esquivel, Jesus [2 ]
Larsen, Stein G. [3 ]
Liauw, Winston [4 ,5 ]
Alzahrani, Nayef A. [6 ]
Morris, David L. [6 ]
Kepenekian, Vahan [7 ,8 ]
Sourrouille, Isabelle [9 ]
Dumont, Frederic [10 ]
Tuech, Jean-Jacques [11 ]
Ceribelli, Cecilia [12 ]
Doussot, Beranger [13 ]
Sgarbura, Olivia [14 ]
Quenet, Francois [14 ]
Glehen, Olivier [7 ,8 ]
Fisher, Oliver M. [5 ,6 ,15 ]
机构
[1] Uppsala Univ, Dept Surg Sci, Sect Surg, Akad Sjukhuset, S-75185 Uppsala, Sweden
[2] Beebe Healthcare, Div Surg Oncol, Lewes, DE USA
[3] Oslo Univ Hosp, Dept Gastroenterol Surg, Sect Surg Oncol, N-0372 Oslo, Norway
[4] UNSW Australia, St George & Sutherland Clin Sch, Sydney, NSW, Australia
[5] St George Hosp, Dept Med Oncol, Sydney, NSW, Australia
[6] St George Hosp, Dept Surg, Sydney, NSW, Australia
[7] Hosp Civils Lyon, Hosp Lyon Sud, Lyon, France
[8] Univ Lyon 1, CICLY, Lyon, France
[9] Inst Gustave Roussy, Dept Surg, Villejuif, France
[10] Inst Cancerol lOuest, Dept Oncol Surg, St Herblain, France
[11] Ctr Hospitalo Univ Rouen, Dept Digest Surg, Rouen, France
[12] Ctr Hospitalo Univ Archet II, Dept Surg, Nice, France
[13] Ctr Hosp Univ Dijon Bourgogne, Dept Digest Surg, Dijon, France
[14] Univ Montpellier, Canc Inst Montpellier, Dept Surg Oncol, Montpellier, France
[15] Notre Dame Univ, Sch Med, Sydney, NSW, Australia
关键词
Colorectal cancer; Peritoneal metastases; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Neoadjuvant chemotherapy; Adjuvant chemotherapy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; NEOADJUVANT CHEMOTHERAPY; SYSTEMIC THERAPY; CARCINOMATOSIS; PROGNOSIS; MANAGEMENT;
D O I
10.1016/j.eclinm.2022.101746
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is a paucity of studies evaluating perioperative systemic chemotherapy in conjunction with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer peritoneal metastases (CRCPM). The aim was to evaluate neoadjuvant and/or adjuvant systemic therapy in CRCPM. Methods Patients with CRCPM from 39 treatment centres globally from January 1, 1991, to December 31, 2018, who underwent CRS+HIPEC were identified and stratified according to neoadjuvant/adjuvant use. Crude data analysis, propensity score matching (PSM) and Cox-proportional hazard modelling was performed. Findings Of 2093 patients, 1613 were included in neoadjuvant crude evaluation with 708 in the PSM cohort (354 patients/arm). In the adjuvant evaluation, 1176 patients were included in the crude cohort with 778 in the PSM cohort (389 patients/arm). The median overall survival (OS) in the PSM cohort receiving no neoadjuvant vs neoadjuvant therapy was 37.0 months (95% CI: 32.6-42.7) vs 34.7 months (95% CI: 31.2-38.8, HR 1.08 95% CI: 0.88-1.32, p = 0.46). The median OS in the PSM cohort receiving no adjuvant therapy vs adjuvant therapy was 37.0 months (95% CI: 32.9-41.8) vs 45.7 months (95% CI: 38.8-56.2, HR 0.79 95% CI: 0.64-0.97, p = 0.022). Recurrence-free survival did not differ in the neoadjuvant evaluation but differed in the adjuvant evaluation - HR 1.04 (95% CI: 0.87-1.25, p = 0.66) and 0.83 (95% CI: 0.70-0.98, p = 0.03), respectively. Multivariable Cox-proportional hazard modelling in the crude cohorts showed hazard ratio 1.08 (95% CI: 0.92-1.26, p = 0.37) for administering neoadjuvant therapy and 0.86 (95% CI: 0.72-1.03, p = 0.095) for administering adjuvant therapy. Interpretation Neoadjuvant therapy did not confer a benefit to patients undergoing CRS+HIPEC for CRCPM, whereas adjuvant therapy was associated with a benefit in this retrospective setting. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:12
相关论文
共 19 条
[11]   Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study [J].
Maillet, Marianne ;
Glehen, Olivier ;
Lambert, Jerome ;
Goere, Diane ;
Pocard, Marc ;
Msika, Simon ;
Passot, Guillaume ;
Elias, Dominique ;
Eveno, Clarisse ;
Sabate, Jean-Marc ;
Lourenco, Nelson ;
Andre, Thierry ;
Gornet, Jean-Marc .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (03) :863-869
[12]   Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin [J].
Nagourney, Robert A. ;
Evans, Steven ;
Tran, Peter H. ;
Nagourney, Adam J. ;
Sugarbaker, Paul H. .
EJSO, 2021, 47 (04) :738-742
[13]   Pathological Response to Neoadjuvant Chemotherapy: A New Prognosis Tool for the Curative Management of Peritoneal Colorectal Carcinomatosis [J].
Passot, Guillaume ;
You, Benoit ;
Boschetti, Gilles ;
Fontaine, Juliette ;
Isaac, Sylvie ;
Decullier, Evelyne ;
Maurice, Christele ;
Vaudoyer, Delphine ;
Gilly, Francois-Noel ;
Cotte, Eddy ;
Glehen, Olivier .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (08) :2608-2614
[14]   Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis [J].
Passot, Guillaume ;
Vaudoyer, Delphine ;
Cotte, Eddy ;
You, Benoit ;
Isaac, Sylvie ;
Gilly, Francois Noel ;
Mohamed, Faheez ;
Glehen, Olivier .
ANNALS OF SURGERY, 2012, 256 (01) :125-129
[15]   Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial [J].
Quenet, Francois ;
Elias, Dominique ;
Roca, Lise ;
Goere, Diane ;
Ghouti, Laurent ;
Pocard, Marc ;
Facy, Olivier ;
Arvieux, Catherine ;
Lorimier, Gerard ;
Pezet, Denis ;
Marchal, Frederic ;
Loi, Valeria ;
Meeus, Pierre ;
Juzyna, Beata ;
de Forges, Helene ;
Paineau, Jacques ;
Glehen, Olivier .
LANCET ONCOLOGY, 2021, 22 (02) :256-266
[16]   Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases A Phase 2 Randomized Clinical Trial [J].
Rovers, Koen P. ;
Bakkers, Checca ;
Nienhuijs, Simon W. ;
Burger, Jacobus W. A. ;
Creemers, Geert-Jan M. ;
Thijs, Anna M. J. ;
Brandt-Kerkhof, Alexandra R. M. ;
Madsen, Eva V. E. ;
van Meerten, Esther ;
Tuynman, Jurriaan B. ;
Kusters, Miranda ;
Versteeg, Kathelijn S. ;
Aalbers, Arend G. J. ;
Kok, Niels F. M. ;
Buffart, Tineke E. ;
Wiezer, Marinus J. ;
Boerma, Djamila ;
Los, Maartje ;
de Reuver, Philip R. ;
Bremers, Andreas J. A. ;
Verheul, Henk M. W. ;
Kruijff, Schelto ;
de Groot, Derk Jan A. ;
Witkamp, Arjen J. ;
van Grevenstein, Wilhelmina M. U. ;
Koopman, Miriam ;
Nederend, Joost ;
Lahaye, Max J. ;
Kranenburg, Onno ;
Fijneman, Remond J. A. ;
van 't Erve, Iris ;
Snaebjornsson, Petur ;
Hemmer, Patrick H. J. ;
Dijkgraaf, Marcel G. W. ;
Punt, Cornelis J. A. ;
Tanis, Pieter J. ;
de Hingh, Ignace H. J. T. .
JAMA SURGERY, 2021, 156 (08) :710-720
[17]   Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases [J].
Rovers, Koen P. ;
Bakkers, Checca ;
van Erning, Felice N. ;
Burger, Jacobus W. A. ;
Nienhuijs, Simon W. ;
Simkens, Geert A. A. M. ;
Creemers, Geert-Jan M. ;
Hemmer, Patrick H. J. ;
Punt, Cornelis J. A. ;
Lemmens, Valery E. P. P. ;
Tanis, Pieter J. ;
de Hingh, Ignace H. J. T. .
JAMA ONCOLOGY, 2020, 6 (08)
[18]   Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6) [J].
Rovers, Koen P. ;
Bakkers, Checca ;
Simkens, Geert A. A. M. ;
Burger, Jacobus W. A. ;
Nienhuijs, Simon W. ;
Creemers, Geert-Jan M. ;
Thijs, Anna M. J. ;
Brandt-Kerkhof, Alexandra R. M. ;
Madsen, Eva V. E. ;
Ayez, Ninos ;
de Boer, Nadine L. ;
van Meerten, Esther ;
Tuynman, Jurriaan B. ;
Kusters, Miranda ;
Sluiter, Nina R. ;
Verheul, Henk M. W. ;
van der Vliet, Hans J. ;
Wiezer, Marinus J. ;
Boerma, Djamila ;
Wassenaar, Emma C. E. ;
Los, Maartje ;
Hunting, Cornelis B. ;
Aalbers, Arend G. J. ;
Kok, Niels F. M. ;
Kuhlmann, Koert F. D. ;
Boot, Henk ;
Chalabi, Myriam ;
Kruijff, Schelto ;
Been, Lukas B. ;
van Ginkel, Robert J. ;
de Groot, Derk Jan A. ;
Fehrmann, Rudolf S. N. ;
de Wilt, Johannes H. W. ;
Bremers, Andreas J. A. ;
de Reuver, Philip R. ;
Radema, Sandra A. ;
Herbschleb, Karin H. ;
van Grevenstein, Wilhelmina M. U. ;
Witkamp, Arjen J. ;
Koopman, Miriam ;
Mohammad, Nadia Haj ;
van Duyn, Eino B. ;
Mastboom, Walter J. B. ;
Mekenkamp, Leonie J. M. ;
Nederend, Joost ;
Lahaye, Max J. ;
Snaebjornsson, Petur ;
Verhoef, Cornelis ;
van Laarhoven, Hanneke W. M. ;
Zwinderman, Aeilko H. .
BMC CANCER, 2019, 19 (1)
[19]   Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review [J].
Rovers, Koen P. ;
Simkens, Geert A. ;
Punt, Cornelis J. ;
van Dieren, Susan ;
Tanis, Pieter J. ;
de Hingh, Ignace H. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 114 :53-62